Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol (Q44193627)

30 November 2017

Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol (English)

1 reference

30 November 2017

4

René S Kahn

1 reference

30 November 2017

Bob Oranje

1

1 reference

30 November 2017

Christine C Gispen-de Wied

series ordinal

2

1 reference

30 November 2017

Marinus Nicholaas Verbaten

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

Biological Psychiatry

1 reference

30 November 2017

52

1 reference

30 November 2017

887-895

1 reference

30 November 2017

9

1 reference

Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Schizophrenia, sensory gating, and nicotinic receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Replication and extension of P50 findings in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Sensorimotor gating and schizophrenia. Human and animal model studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Gating and habituation of the startle reflex in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Prestimulus effects on human startle reflex in normals and schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Clinical and sensorimotor gating effects of ketamine in normals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

A diagnostic interview: the schedule for affective disorders and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Elementary neuronal dysfunctions in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Stereoselective high-performance liquid chromatographic determination of the enantiomers of ketamine and norketamine in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Habituation of the Blink reflex in normals and schizophrenic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Startle habituation and sensorimotor gating in schizophrenia and related animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Presidential Address, 1974. The more or less startling effects of weak prestimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Startle gating deficits occur across prepulse intensities in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Removal of the ocular artifact from the EEG: a comparison of time and frequency domain methods with simulated and real data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

The neurobiology of startle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers.

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Prepulse Inhibition of the Startle Response in Men With Schizophrenia: Effects of Age of Onset of Illness, Symptoms, and Medication

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Excitatory amino acids as a final common pathway for neurologic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Model psychoses and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

"Early" and "late" effects of sustained haloperidol on apomorphine- and phencyclidine-induced sensorimotor gating deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Disorders of attention and perception in early schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Gating of auditory P50 in schizophrenics: unique effects of clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

The effects of a sub-anaesthetic dose of ketamine on human selective attention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

The neural substrates of sensorimotor gating of the startle reflex: a review of recent findings and their implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

Replication of a P50 auditory gating deficit in Australian patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

CSF monoamine metabolites in patients and controls: support for a bimodal distribution in major affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901377-X

10.1016/S0006-3223(02)01377-X

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference